下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Product Data SheetSalidrosideCat. No.: HY-N0109CAS No.: 10338-51-9分式: CHO分量: 300.3作靶點(diǎn): mTOR; Apoptosis作通路: PI3K/Akt/mTOR; Apoptosis儲(chǔ)存式: 4C, protect from light* In solvent : -80C, 6 months; -20C, 1 month (protect from light)溶解性數(shù)據(jù)體外實(shí)驗(yàn) H2O : 100 mg/mL (333.00 mM)* means soluble, but saturation unknown.
2、SolventMass1 mg 5 mg 10 mgConcentration制備儲(chǔ)備液1 mM 3.3300 mL 16.6500 mL 33.3000 mL5 mM 0.6660 mL 3.3300 mL 6.6600 mL10 mM 0.3330 mL 1.6650 mL 3.3300 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。儲(chǔ)備液的保存式和期限:-80C, 6 months; -20C, 1 month (protect from light)。-80C 儲(chǔ)存時(shí),請(qǐng)?jiān)?6 個(gè)內(nèi)使,-20C 儲(chǔ)存時(shí),請(qǐng)?jiān)?1 個(gè)內(nèi)使
3、。BIOLOGICAL ACTIVITY物活性 Salidroside種脯氨酰內(nèi)肽酶 (prolyl endopeptidase) 抑制劑。Salidroside 可通過(guò)激活 mTOR 信號(hào)緩解腫瘤惡病質(zhì)模型中的惡病質(zhì)癥狀。Salidroside 還能通過(guò)增強(qiáng) PINK1/Parkin 介導(dǎo)的線粒體噬來(lái)保護(hù)多巴胺能神經(jīng)元。IC & Target mTOR體外研究Salidroside (100 M) inhibits prolyl endopeptidase (PEP) activity (10.61.9%). Prolyl endopeptidase is an enzyme thatpla
4、ys a role in the metabolism of proline-containing neuropeptidase which is recognized to be involved in learningand memory1. Salidroside, one of the major phenylpropanoid glycosides found in R. rosea L, is consumed almostdaily as a nutritional supplement in many countries and has been identified poss
5、essing potential anti-fatigue andanoxia,anti-aging, and anti-Alzheimers disease activities. Salidroside can improve muscle nutrition via increasingmTOR, p-mTOR, and MyHC expression2. SH-SY5Y cells are exposed to 0-600 M MPP+ for 12-48 h and the resultsshow that MPP+ results in a significant decrease
6、 of cell viability in a concentration and time-dependent manner. Cellsare pretreated with 25-100 M Salidroside (Sal) for 24 h and then exposed to 500 M MPP+ for an additional 24 h.Page 1 of 2 www.MedChemESalidroside concentration-dependently prevents MPP+-induced decrease of cell viability. Annexin
7、V/PI staining is acommon method for the detection of apoptotic cell. Salidroside significantly decreases the number of Annexin V/PI-stained cells treated by MPP+ which is in a concentration-dependent manner. Apoptotic cell could also bemorphologically evaluated by Hoechst staining. In Hoechst staini
8、ng, apoptotic cells are characterized by reducednuclear size, chromatin condensation, intense fluorescence, and nuclear fragmentation. Salidroside notably inhibitsMPP+-induced increase of chromatin condensation, intense fluorescence, and nuclear fragmentation in SH-SY5Y cells3.體內(nèi)研究 Salidroside is a
9、natural antioxidant extracted from medicinal food plant Rhodiola rosea. Salidroside (100 mg/kg/day)shows strong glucose lowering effect on db/db mice which is similar to effect of Metformin (200 mg/kg/day). For thisreason, the dose of 100 mg/kg/day salidroside is used4.PROTOCOLCell Assay 3 SH-SY5Y c
10、ells are seeded in 96-well plates at 1104 cells per well. After the treatment with Salidroside (25-100 M)and MPP+, cell viability is measured by MTT assay. Briefly, cells are incubated with 500 g/mL MTT at 37C for 4 h.After that, the medium is removed and 150 L DMSO is added and shaking is conducted
11、 for 10 min. Absorbance ismeasured at 570 nm in a microplate reader and the results are expressed as folds of control3.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal Mice4Administration 4 The 4-week-old male C57BL/6 mice are fed a high-fat diet
12、(HFD) (n=16) or normal chow diet (n=8). After 10 weeks ofthe HFD, salidroside intervention (100 mg/kg/day) is initiated by gavage once a day for 5 weeks. The control groupsare given vehicle (saline). The 4-week-old male C57Bl/KsJ (BKS) mice (wild type, n=8) and BKS.Cg-Dock7m +/+Leprdb/J (db/db) mice
13、 (n=16) are used. Salidroside (100 mg/kg/day) is administrated orally by gavage once a day for5 weeks. The control groups are given vehicle (saline). Fasting blood glucose and body weight of mice are monitoredevery 5 days. Glucose measurements are performed on blood drawn from the tail vein using a
14、Glucometer.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2072-2082. Int J Oncol. 2019 Jun;54(6):1969-1980. Int Immunopharmacol. 2020 Feb.See more customer validations on HYPERLINK www.MedChemE ww
15、w.MedChemEREFERENCES1. Fan W, et al. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sachalinensis. Chem Pharm Bull (Tokyo). 2001 Apr;49(4):396-401.2. Chen X, et al. Salidroside alleviates cachexia symptoms in mouse models of cancer cachexia via activatingmTOR signalling. J Cac
16、hexia Sarcopenia Muscle.2016 May;7(2):225-32.3. Wu L, et al. Salidroside Protects against MPP+-Induced Neuronal Injury through DJ-1-Nrf2 Antioxidant Pathway. Evid Based Complement Alternat Med.2017;2017:5398542.4. Ju L, et al. Salidroside, A Natural Antioxidant, Improves -Cell Survival and Function via Activating AMPK Pathway. Front Pharmacol. 2017 Oct 18;8:749.Page 2 of 3 www.MedChemE5. Li R, et al. Salidroside Protects Dopaminergic Neurons by Enhancing PINK1/Parkin-Mediated Mitophagy. Oxid Med Cell Lo
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 2024年版高校專利技術(shù)轉(zhuǎn)讓合同
- 2024-2030年中國(guó)大棗飲料行業(yè)銷售模式及投資盈利預(yù)測(cè)報(bào)告
- 2024-2030年中國(guó)城市電視臺(tái)行業(yè)發(fā)展策略及投資運(yùn)作模式分析報(bào)告
- 2024年農(nóng)業(yè)產(chǎn)業(yè)投資合同擔(dān)保協(xié)議3篇
- 2024年校園水電設(shè)施改造與維護(hù)服務(wù)合同3篇
- 馬鞍山師范高等??茖W(xué)校《物聯(lián)網(wǎng)應(yīng)用概論》2023-2024學(xué)年第一學(xué)期期末試卷
- 2024年創(chuàng)新創(chuàng)業(yè)項(xiàng)目投資評(píng)估與咨詢服務(wù)協(xié)議3篇
- 2024年度自動(dòng)駕駛汽車勞動(dòng)合同與聘用合同3篇
- 2024年標(biāo)準(zhǔn)化信息技術(shù)外包服務(wù)合同一
- 2024年度行政合同科技創(chuàng)新合同糾紛救濟(jì)與保障協(xié)議2篇
- 機(jī)器學(xué)習(xí)(山東聯(lián)盟)智慧樹(shù)知到期末考試答案章節(jié)答案2024年山東財(cái)經(jīng)大學(xué)
- 德勤公司概況簡(jiǎn)介
- DB32∕T 2156-2012 電梯能耗測(cè)試及能效分級(jí)
- 瀝青路面日常養(yǎng)護(hù)及維修施工要點(diǎn)(大量附圖共143頁(yè))
- 《色彩基礎(chǔ)知識(shí)》PPT課件(詳解)
- 《保健按摩師》(二級(jí))理論知識(shí)鑒定要素細(xì)目表
- 甘蔗制糖簡(jiǎn)介
- 三秦出版社五年級(jí)上冊(cè)綜合實(shí)踐教案
- 屋頂分布式光伏項(xiàng)目安全文明施工控制措施
- 水泥保證供應(yīng)實(shí)施方案及服務(wù)承諾書
- 2022機(jī)要密碼工作總結(jié)機(jī)要室工作總結(jié).doc
評(píng)論
0/150
提交評(píng)論